Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionEtf Managers Group, Llc
Latest Disclosed Ownership18,918 shares
Latest Disclosed Value $ 5,960,495
Etf Managers Group, Llc reports 594.49% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On April 18, 2023 - Etf Managers Group, Llc filed a 13F-HR form disclosing ownership of 18,918 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $5,960,494 USD as of March 31, 2023. The entity filed a previous 13F-HR on March 23, 2023 disclosing 2,724 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 594.49% during the quarter. The current value of the position is $8,453,130 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2023-04-18 2023-03-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 18,918 16,194 594.49 5,960 658.27 0.1594
2023-03-23 2022-12-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 2,724 -2,847 -51.10 787 -51.27 0.0369
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 5,571 -663 -10.64 1,613 -7.72 0.0518
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 6,234 3,000 92.76 1,748 110.60 0.0506
2022-05-13 2022-03-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 3,234 56 1.76 830 17.40 0.0167
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 3,178 150 4.95 707 28.08 0.0140
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 3,028 234 8.38 552 0.36 0.0104
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 2,794 1,455 108.66 550 92.98 0.0090
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 1,339 175 15.03 285 5.17 0.0051
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 1,164 -1,457 -55.59 271 -61.72 0.0059
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 2,621 -1,092 -29.41 708 -33.14 0.0225
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 3,713 3,713 1,059 0.0376
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 0 -877 -100.00 0 -100.00
2019-05-07 2019-03-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 877 73 9.08 161 21.05 0.0079
2019-02-01 2018-12-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 804 120 17.54 133 0.76 0.0063
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 684 72 11.76 132 83.33 0.0050
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 612 -30 -4.67 72 -28.00 0.0052
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 642 80 14.23 100 16.28 0.0061
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 562 80 16.60 86 17.81 0.0062
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 482 40 9.05 73 28.07 0.0062
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 442 144 48.32 57 72.73 0.0048
2017-05-15 2016-03-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 298 298 33 0.0241
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.